The diabetic shoes market size is projected to be valued at US$ 8.6 billion in 2023, and is expected to rise to US$ 16.0 billion by 2033. The sales of diabetic shoes are expected to expand at a significant CAGR of 6.4% during the forecast period.
Various Factors Propelling the Demand for Diabetic Shoes are
To minimize the danger of the consequences of diabetic foot ulcers and limb amputation, individuals are moving their choice toward preventative care, as the burden of diabetes affects many people worldwide.
The World Health Organization reports that more than 50% of diabetics who are at risk for limb injuries also have peripheral neuropathies, which has the additional consequence of raising mortality rates globally.
Since more diabetic patients are becoming aware of the benefits of wearing diabetic footwear, the market for diabetic shoes is expanding significantly on a global scale. Customized and predesigned diabetic shoes with certain key features are growing in popularity among diabetic patients worldwide.
The global population's unhealthy and hectic lifestyle is further boosting the demand for different medical footwear. In addition, the rising elderly population worldwide is probably going to elevate market growth shortly.
Customers are now being encouraged to purchase diabetic shoes and other diabetic products online, due to the existence of an efficient online platform by key players and increased internet penetration.
Long-term market expansion is strongly supported by expanding infrastructure facilities associated with distribution outlets and specialty shoe shops.
As a result of advancements in the protective footwear market and increased research and development activities to combat diabetic foot ulcers, the global medical footwear market is likely to grow significantly during the forecast period.
Several government and non-government organizations are researching to better understand diabetic foot ulcers and their patterns. For example, the National Institutes of Health-funded Diabetic Foot Consortium (DFC) was established in 2020 to study diabetic foot ulcers.
The development of personalized and stylish diabetic footwear by leading manufacturers to keep up with the current fashion trend is playing a significant role in the market's expansion.
| Attribute | Details |
|---|---|
| Diabetic Shoes Market Estimated Size (2023) | US$ 8.6 billion |
| Diabetic Shoes Market CAGR (2023 to 2033) | 6.4% |
| Diabetic Shoes Market Forecasted Size (2033) | US$ 16.0 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global demand for diabetic shoes is predicted to witness a healthy CAGR of 6.4% between 2023 and 2033, in comparison to the 4.1% CAGR registered from 2017 to 2022. Growth in the diabetic shoes market is attributed to the increase in the prevalence of diabetes, growing awareness about the availability of medical footwear products across developing regions, increasing need for better foot care, new product launches, and favorable government support.
Diabetic shoes are unique footwear products designed to preserve diabetic feet, as well as to reduce skin breakdown due to neuropathy, impaired mobility, and deformities. These diabetic shoes have flexible uppers and an extra-thickness design for a pressure-free fit. They provide better motion control, prevent skin breakdown, promote circulation, reduce calluses formation, and thus eliminate the risk of foot problems in high-pressure areas of the foot.
The rapid surge in cases of diabetes and diabetic ulcers is a significant factor boosting growth of the market. According to the International Diabetes Federation (IDF), diabetic foot and lower limb complications have become serious health problems, affecting 40 to 60 million people with diabetes globally. These health conditions (chronic ulcers and amputations) significantly reduce the quality of life and increase the risk of early death. To counter this and minimize the risk of infections, people use preventive healthcare products like diabetic shoes. This is likely to continue to expand the global diabetic shoes market size during the forecast period.
The global market for diabetic shoes is divided into categories based on product type, including dress shoes, walking shoes, and running shoes. Due to the quick adoption of diabetic dress shoes by customers, the dress shoes segment had a prominent share of all of these at 43.4% in 2021, and is anticipated to expand at a significant rate throughout the forecast period.
As the market is significantly expanding, diabetic shoes are becoming well-liked among working professionals in industrialized nations. Additionally, these shoes offer additional defense against foot injuries, lowering the risk of fungus infections. It is anticipated that the launch of diabetic shoes made of cutting-edge materials like cotton, nylon, and leather is likely to present manufacturers with lucrative business opportunities.
Based on end-user, women are the front-runner of the segment with a growth rate of 5.8%. Women typically have higher SHBG levels than men do, and low SHBG concentrations may put women at even great risk for developing diabetes than men do. Women are more likely to get diabetes, hence they spend money on caring for and maintaining their bodies. In addition, it is anticipated that during the forecast period, women in developing regions are more likely to become aware of diabetes and its effects on their health due to rising awareness and campaigns.
Principal Consultant
Given the high prevalence of both type 1 and type 2 diabetes among the population in the United States, as well as the high consumption of such products in the region, the North America market holds a prominent share of the global market. According to information provided by the United States Department of Health and Human Resources, 34.2 million Americans had diabetes as of 2018. Additionally, the growing consciousness of people about health and hygiene, as well as healthcare product spending, contribute to the region's higher sales of diabetic shoes.
| United States Market Size (US$ million/billion) by End of Forecast Period (2033) | US$ 5.7 billion |
|---|---|
| United States Market Absolute Dollar Growth (US$ million/billion) | US$ 2.5 billion |
| CAGR % 2017 to 2022 | 9.7% |
| CAGR % 2023 to End of Forecast (2033) | 6.1% |
With the prevalence of high levels of health awareness among the populace, the availability of a variety of diabetic shoes, the growth of government initiatives to lessen the burden of diabetes, and the significant presence of top diabetic shoe manufacturers, sales of diabetic shoes are predicted to increase across the United Kingdom at a moderate CAGR of 5.4% during the assessment period.
Around 3.9 million people in the United Kingdom had diabetes in 2019, and 90% of those had type 2 diabetes, according to Diabetes United kingdom, a British diabetic association.
The market for diabetic footwear shoes in the United Kingdom is also likely to see growth opportunities due to rising consumer expenditure on diabetic shoe purchases made online and the growing demand for diabetic shoes for women.
| United Kingdom Market Size (US$ million/billion) by End of Forecast Period (2033) | US$ 673.3 million |
|---|---|
| United Kingdom Market Absolute Dollar Growth (US$ million/billion) | US$ 277.1 million |
| CAGR % 2017 to 2022 | 8.8% |
| CAGR % 2023 to End of Forecast (2033) | 5.4% |
A hectic lifestyle and changing eating habits have led to an increase in the prevalence of diabetes and obesity. Growing consumer knowledge of diabetes and related illnesses is predicted to open up significant business prospects in the region's developing nations, including China and India.
India region has experienced a significant increase, which is related to the high number of footwear items imported and shows rising demand for diabetic shoes in the area. The World Bank Organization reports that the value of India's footwear imports from Italy in 2018 was US$ 23.07 million. The population's increasing interest in sports and leisure activities is another factor boosting the need for diabetic shoes in the area.
Due to the prevalence of type 2 diabetes, which ranges from about 2% in the People's Republic of China to a wide spectrum of adult populations, several leading businesses are investing in the Asia Pacific area. The diabetic shoes market is anticipated to expand in other areas as well, due to an increase in the elderly population and the introduction of better diabetic footwear.
| China Market Size (US$ million/billion) by End of Forecast Period (2033) | US$ 1.1 billion |
|---|---|
| China Market Absolute Dollar Growth (US$ million/billion) | US$ 492.4 million |
| CAGR % 2017 to 2022 | 9.3% |
| CAGR % 2023 to End of Forecast (2033) | 5.8% |
The top competitors in the diabetic footwear industry have made it a priority to offer consumers specialized solutions as one of their primary methods to capture a sizeable portion of the market. The leading players have also benefited from strategies like product launches and acquisitions to increase their market position in the diabetic footwear industry.
Latest Developments:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Asics, Drewshoe, Incorporated, Orthofeet Inc., DARCO International, Inc., Clearwell Mobility Company, Supad, Aetrex Worldwide, Inc., Gravity Defyer Corp., Kinetec Medical Products Ltd, Horng Shin Footwear Co., Watts Footwear, DJO, LLC (Dr. Comfort), Advance Diabetic Solution, Dr. Zen Products, Inc., and Sensoria Health
| Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.4% from 2023 to 2033 |
| Base Year of Estimation | 2023 |
| Historical Data | 2017 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ billion and Volume in Units and F-CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis |
| Key Segments Covered | Product Type, Patient Type, Width, Sales Channel, End User, By Region |
| Regions Covered | North America; Latin America; Europe; East Asia; South Asia; The Middle East & Africa; Oceania |
| Key Countries Profiled | United States, Canada, Brazil, Mexico, Germany, Italy, France, United Kingdom, Spain, Russia, China, Japan, India, GCC Countries, Australia |
| Key Companies Profiled | Asics; Drewshoe; Incorporated; Orthofeet Inc.; DARCO International, Inc.; Clearwell Mobility Company; Supad; Aetrex Worldwide, Inc.; Gravity Defyer Corp.; Kinetec Medical Products Ltd; Horng Shin Footwear Co.; Watts Footwear; DJO, LLC (Dr. Comfort); Advance Diabetic Solution; Dr. Zen Products, Inc.; and Sensoria Health |
| Customization & Pricing | Available upon Request |
The worldwide diabetic shoes market is expected to be valued at US$ 8.6 billion in 2023.
Asics, Drewshoe, Incorporated, and Orthofeet Inc., are the leading diabetic shoes industry players.
The diabetic shoes industry is set to surge at a CAGR of 6.4% from 2023 to 2033.
United States is anticipated to generate US$ 5.7 billion revenue by 2033.
Rising life expectancy and greater awareness of obesity's risks are expected to boost product demand.
1. Executive Summary | Diabetic Shoes Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2017 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Dress Shoes
5.3.2. Running Shoes
5.3.3. Strolling Shoes
5.3.4. Others
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Patient Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Patient Type, 2017 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Patient Type, 2023 to 2033
6.3.1. Outpatient
6.3.2. Inpatient
6.4. Y-o-Y Growth Trend Analysis By Patient Type, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By Patient Type, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2017 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
7.3.1. Men
7.3.2. Women
7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022
7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Width
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Width, 2017 to 2022
8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Width, 2023 to 2033
8.3.1. Narrow
8.3.2. Medium
8.3.3. Wide
8.3.4. Others
8.4. Y-o-Y Growth Trend Analysis By Width, 2017 to 2022
8.5. Absolute $ Opportunity Analysis By Width, 2023 to 2033
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Sales Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Sales Channel, 2017 to 2022
9.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Sales Channel, 2023 to 2033
9.3.1. Direct Sales
9.3.2. Footwear Specialty Stores
9.3.3. Medical & Healthcare Centres
9.3.4. Online Retailers
9.3.5. Mono-Brand Stores
9.3.6. Other Sales Channel
9.4. Y-o-Y Growth Trend Analysis By Sales Channel, 2017 to 2022
9.5. Absolute $ Opportunity Analysis By Sales Channel, 2023 to 2033
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2017 to 2022
10.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. USA
11.2.1.2. Canada
11.2.2. By Product Type
11.2.3. By Patient Type
11.2.4. By End User
11.2.5. By Width
11.2.6. By Sales Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Patient Type
11.3.4. By End User
11.3.5. By Width
11.3.6. By Sales Channel
11.4. Key Takeaways
12. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Argentina
12.2.1.4. Rest of Latin America
12.2.2. By Product Type
12.2.3. By Patient Type
12.2.4. By End User
12.2.5. By Width
12.2.6. By Sales Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Patient Type
12.3.4. By End User
12.3.5. By Width
12.3.6. By Sales Channel
12.4. Key Takeaways
13. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Germany
13.2.1.2. France
13.2.1.3. Italy
13.2.1.4. United kingdom
13.2.1.5. Spain
13.2.1.6. BENELUX
13.2.1.7. Russia
13.2.1.8. Rest of Europe
13.2.2. By Product Type
13.2.3. By Patient Type
13.2.4. By End User
13.2.5. By Width
13.2.6. By Sales Channel
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Patient Type
13.3.4. By End User
13.3.5. By Width
13.3.6. By Sales Channel
13.4. Key Takeaways
14. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product Type
14.2.3. By Patient Type
14.2.4. By End User
14.2.5. By Width
14.2.6. By Sales Channel
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Patient Type
14.3.4. By End User
14.3.5. By Width
14.3.6. By Sales Channel
14.4. Key Takeaways
15. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. India
15.2.1.2. Indonesia
15.2.1.3. Malaysia
15.2.1.4. Singapore
15.2.1.5. Thailand
15.2.1.6. Rest of South Asia
15.2.2. By Product Type
15.2.3. By Patient Type
15.2.4. By End User
15.2.5. By Width
15.2.6. By Sales Channel
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Patient Type
15.3.4. By End User
15.3.5. By Width
15.3.6. By Sales Channel
15.4. Key Takeaways
16. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. Australia
16.2.1.2. New Zealand
16.2.2. By Product Type
16.2.3. By Patient Type
16.2.4. By End User
16.2.5. By Width
16.2.6. By Sales Channel
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Product Type
16.3.3. By Patient Type
16.3.4. By End User
16.3.5. By Width
16.3.6. By Sales Channel
16.4. Key Takeaways
17. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
17.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
17.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
17.2.1. By Country
17.2.1.1. GCC Countries
17.2.1.2. South Africa
17.2.1.3. Rest of Middle East and Africa
17.2.2. By Product Type
17.2.3. By Patient Type
17.2.4. By End User
17.2.5. By Width
17.2.6. By Sales Channel
17.3. Market Attractiveness Analysis
17.3.1. By Country
17.3.2. By Product Type
17.3.3. By Patient Type
17.3.4. By End User
17.3.5. By Width
17.3.6. By Sales Channel
17.4. Key Takeaways
18. Key Countries Market Analysis
18.1. USA
18.1.1. Pricing Analysis
18.1.2. Market Share Analysis, 2022
18.1.2.1. By Product Type
18.1.2.2. By Patient Type
18.1.2.3. By End User
18.1.2.4. By Width
18.1.2.5. By Sales Channel
18.2. Canada
18.2.1. Pricing Analysis
18.2.2. Market Share Analysis, 2022
18.2.2.1. By Product Type
18.2.2.2. By Patient Type
18.2.2.3. By End User
18.2.2.4. By Width
18.2.2.5. By Sales Channel
18.3. Brazil
18.3.1. Pricing Analysis
18.3.2. Market Share Analysis, 2022
18.3.2.1. By Product Type
18.3.2.2. By Patient Type
18.3.2.3. By End User
18.3.2.4. By Width
18.3.2.5. By Sales Channel
18.4. Mexico
18.4.1. Pricing Analysis
18.4.2. Market Share Analysis, 2022
18.4.2.1. By Product Type
18.4.2.2. By Patient Type
18.4.2.3. By End User
18.4.2.4. By Width
18.4.2.5. By Sales Channel
18.5. Argentina
18.5.1. Pricing Analysis
18.5.2. Market Share Analysis, 2022
18.5.2.1. By Product Type
18.5.2.2. By Patient Type
18.5.2.3. By End User
18.5.2.4. By Width
18.5.2.5. By Sales Channel
18.6. Germany
18.6.1. Pricing Analysis
18.6.2. Market Share Analysis, 2022
18.6.2.1. By Product Type
18.6.2.2. By Patient Type
18.6.2.3. By End User
18.6.2.4. By Width
18.6.2.5. By Sales Channel
18.7. France
18.7.1. Pricing Analysis
18.7.2. Market Share Analysis, 2022
18.7.2.1. By Product Type
18.7.2.2. By Patient Type
18.7.2.3. By End User
18.7.2.4. By Width
18.7.2.5. By Sales Channel
18.8. Italy
18.8.1. Pricing Analysis
18.8.2. Market Share Analysis, 2022
18.8.2.1. By Product Type
18.8.2.2. By Patient Type
18.8.2.3. By End User
18.8.2.4. By Width
18.8.2.5. By Sales Channel
18.9. United kingdom
18.9.1. Pricing Analysis
18.9.2. Market Share Analysis, 2022
18.9.2.1. By Product Type
18.9.2.2. By Patient Type
18.9.2.3. By End User
18.9.2.4. By Width
18.9.2.5. By Sales Channel
18.10. Spain
18.10.1. Pricing Analysis
18.10.2. Market Share Analysis, 2022
18.10.2.1. By Product Type
18.10.2.2. By Patient Type
18.10.2.3. By End User
18.10.2.4. By Width
18.10.2.5. By Sales Channel
18.11. BENELUX
18.11.1. Pricing Analysis
18.11.2. Market Share Analysis, 2022
18.11.2.1. By Product Type
18.11.2.2. By Patient Type
18.11.2.3. By End User
18.11.2.4. By Width
18.11.2.5. By Sales Channel
18.12. Russia
18.12.1. Pricing Analysis
18.12.2. Market Share Analysis, 2022
18.12.2.1. By Product Type
18.12.2.2. By Patient Type
18.12.2.3. By End User
18.12.2.4. By Width
18.12.2.5. By Sales Channel
18.13. China
18.13.1. Pricing Analysis
18.13.2. Market Share Analysis, 2022
18.13.2.1. By Product Type
18.13.2.2. By Patient Type
18.13.2.3. By End User
18.13.2.4. By Width
18.13.2.5. By Sales Channel
18.14. Japan
18.14.1. Pricing Analysis
18.14.2. Market Share Analysis, 2022
18.14.2.1. By Product Type
18.14.2.2. By Patient Type
18.14.2.3. By End User
18.14.2.4. By Width
18.14.2.5. By Sales Channel
18.15. South Korea
18.15.1. Pricing Analysis
18.15.2. Market Share Analysis, 2022
18.15.2.1. By Product Type
18.15.2.2. By Patient Type
18.15.2.3. By End User
18.15.2.4. By Width
18.15.2.5. By Sales Channel
18.16. India
18.16.1. Pricing Analysis
18.16.2. Market Share Analysis, 2022
18.16.2.1. By Product Type
18.16.2.2. By Patient Type
18.16.2.3. By End User
18.16.2.4. By Width
18.16.2.5. By Sales Channel
18.17. Indonesia
18.17.1. Pricing Analysis
18.17.2. Market Share Analysis, 2022
18.17.2.1. By Product Type
18.17.2.2. By Patient Type
18.17.2.3. By End User
18.17.2.4. By Width
18.17.2.5. By Sales Channel
18.18. Malaysia
18.18.1. Pricing Analysis
18.18.2. Market Share Analysis, 2022
18.18.2.1. By Product Type
18.18.2.2. By Patient Type
18.18.2.3. By End User
18.18.2.4. By Width
18.18.2.5. By Sales Channel
18.19. Singapore
18.19.1. Pricing Analysis
18.19.2. Market Share Analysis, 2022
18.19.2.1. By Product Type
18.19.2.2. By Patient Type
18.19.2.3. By End User
18.19.2.4. By Width
18.19.2.5. By Sales Channel
18.20. Thailand
18.20.1. Pricing Analysis
18.20.2. Market Share Analysis, 2022
18.20.2.1. By Product Type
18.20.2.2. By Patient Type
18.20.2.3. By End User
18.20.2.4. By Width
18.20.2.5. By Sales Channel
18.21. Australia
18.21.1. Pricing Analysis
18.21.2. Market Share Analysis, 2022
18.21.2.1. By Product Type
18.21.2.2. By Patient Type
18.21.2.3. By End User
18.21.2.4. By Width
18.21.2.5. By Sales Channel
18.22. New Zealand
18.22.1. Pricing Analysis
18.22.2. Market Share Analysis, 2022
18.22.2.1. By Product Type
18.22.2.2. By Patient Type
18.22.2.3. By End User
18.22.2.4. By Width
18.22.2.5. By Sales Channel
18.23. GCC Countries
18.23.1. Pricing Analysis
18.23.2. Market Share Analysis, 2022
18.23.2.1. By Product Type
18.23.2.2. By Patient Type
18.23.2.3. By End User
18.23.2.4. By Width
18.23.2.5. By Sales Channel
18.24. South Africa
18.24.1. Pricing Analysis
18.24.2. Market Share Analysis, 2022
18.24.2.1. By Product Type
18.24.2.2. By Patient Type
18.24.2.3. By End User
18.24.2.4. By Width
18.24.2.5. By Sales Channel
19. Market Structure Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Market Share Analysis of Top Players
19.3.1. By Regional
19.3.2. By Product Type
19.3.3. By Patient Type
19.3.4. By End User
19.3.5. By Width
19.3.6. By Sales Channel
20. Competition Analysis
20.1. Competition Deep Dive
20.1.1. DJO, LLC
20.1.1.1. Overview
20.1.1.2. Product Portfolio
20.1.1.3. Profitability by Market Segments
20.1.1.4. Sales Footprint
20.1.1.5. Strategy Overview
20.1.1.5.1. Marketing Strategy
20.1.1.5.2. Product Strategy
20.1.1.5.3. Channel Strategy
20.1.2. Drewshoe
20.1.2.1. Overview
20.1.2.2. Product Portfolio
20.1.2.3. Profitability by Market Segments
20.1.2.4. Sales Footprint
20.1.2.5. Strategy Overview
20.1.2.5.1. Marketing Strategy
20.1.2.5.2. Product Strategy
20.1.2.5.3. Channel Strategy
20.1.3. Orthofeet Inc.
20.1.3.1. Overview
20.1.3.2. Product Portfolio
20.1.3.3. Profitability by Market Segments
20.1.3.4. Sales Footprint
20.1.3.5. Strategy Overview
20.1.3.5.1. Marketing Strategy
20.1.3.5.2. Product Strategy
20.1.3.5.3. Channel Strategy
20.1.4. DARCO International, Inc.
20.1.4.1. Overview
20.1.4.2. Product Portfolio
20.1.4.3. Profitability by Market Segments
20.1.4.4. Sales Footprint
20.1.4.5. Strategy Overview
20.1.4.5.1. Marketing Strategy
20.1.4.5.2. Product Strategy
20.1.4.5.3. Channel Strategy
20.1.5. Clearwell Mobility Company
20.1.5.1. Overview
20.1.5.2. Product Portfolio
20.1.5.3. Profitability by Market Segments
20.1.5.4. Sales Footprint
20.1.5.5. Strategy Overview
20.1.5.5.1. Marketing Strategy
20.1.5.5.2. Product Strategy
20.1.5.5.3. Channel Strategy
20.1.6. Supad
20.1.6.1. Overview
20.1.6.2. Product Portfolio
20.1.6.3. Profitability by Market Segments
20.1.6.4. Sales Footprint
20.1.6.5. Strategy Overview
20.1.6.5.1. Marketing Strategy
20.1.6.5.2. Product Strategy
20.1.6.5.3. Channel Strategy
20.1.7. Aetrex Worldwide, Inc.
20.1.7.1. Overview
20.1.7.2. Product Portfolio
20.1.7.3. Profitability by Market Segments
20.1.7.4. Sales Footprint
20.1.7.5. Strategy Overview
20.1.7.5.1. Marketing Strategy
20.1.7.5.2. Product Strategy
20.1.7.5.3. Channel Strategy
20.1.8. Gravity Defyer Corp.
20.1.8.1. Overview
20.1.8.2. Product Portfolio
20.1.8.3. Profitability by Market Segments
20.1.8.4. Sales Footprint
20.1.8.5. Strategy Overview
20.1.8.5.1. Marketing Strategy
20.1.8.5.2. Product Strategy
20.1.8.5.3. Channel Strategy
20.1.9. Kinetec Medical Products Ltd
20.1.9.1. Overview
20.1.9.2. Product Portfolio
20.1.9.3. Profitability by Market Segments
20.1.9.4. Sales Footprint
20.1.9.5. Strategy Overview
20.1.9.5.1. Marketing Strategy
20.1.9.5.2. Product Strategy
20.1.9.5.3. Channel Strategy
20.1.10. Horng Shin Footwear Co.
20.1.10.1. Overview
20.1.10.2. Product Portfolio
20.1.10.3. Profitability by Market Segments
20.1.10.4. Sales Footprint
20.1.10.5. Strategy Overview
20.1.10.5.1. Marketing Strategy
20.1.10.5.2. Product Strategy
20.1.10.5.3. Channel Strategy
20.1.11. Watts Footwear
20.1.11.1. Overview
20.1.11.2. Product Portfolio
20.1.11.3. Profitability by Market Segments
20.1.11.4. Sales Footprint
20.1.11.5. Strategy Overview
20.1.11.5.1. Marketing Strategy
20.1.11.5.2. Product Strategy
20.1.11.5.3. Channel Strategy
20.1.12. ASICS Corporation
20.1.12.1. Overview
20.1.12.2. Product Portfolio
20.1.12.3. Profitability by Market Segments
20.1.12.4. Sales Footprint
20.1.12.5. Strategy Overview
20.1.12.5.1. Marketing Strategy
20.1.12.5.2. Product Strategy
20.1.12.5.3. Channel Strategy
20.1.13. Advance Diabetic Solution
20.1.13.1. Overview
20.1.13.2. Product Portfolio
20.1.13.3. Profitability by Market Segments
20.1.13.4. Sales Footprint
20.1.13.5. Strategy Overview
20.1.13.5.1. Marketing Strategy
20.1.13.5.2. Product Strategy
20.1.13.5.3. Channel Strategy
20.1.14. Dr Zen Products, Inc.
20.1.14.1. Overview
20.1.14.2. Product Portfolio
20.1.14.3. Profitability by Market Segments
20.1.14.4. Sales Footprint
20.1.14.5. Strategy Overview
20.1.14.5.1. Marketing Strategy
20.1.14.5.2. Product Strategy
20.1.14.5.3. Channel Strategy
20.1.15. Sensoria Health
20.1.15.1. Overview
20.1.15.2. Product Portfolio
20.1.15.3. Profitability by Market Segments
20.1.15.4. Sales Footprint
20.1.15.5. Strategy Overview
20.1.15.5.1. Marketing Strategy
20.1.15.5.2. Product Strategy
20.1.15.5.3. Channel Strategy
21. Assumptions & Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports
Diabetic Shoes Market
